SCHEMBL20169448

SCHEMBL20169448

O=C1NN(C(=O)OCc2ccccc2)Cc2nc[nH]c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
HTR2C P28335 1/20 0.40
PARP1 P09874 1/20 0.39
PARP2 Q9UGN5 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
GRIN2B Q13224 2/20 0.38
CTRB1 P17538 1/20 0.38
P2RX4 Q99571 1/20 0.37
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
CYP2C19 P33261 1/20 0.37
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25794336 0.71 NPC1 (0.48) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL13518994 0.71 KDR (0.54) NPC1RAB9ASMN1; SMN2GAAPARP1
SCHEMBL6421762 0.71 KDR (0.49) NPC1RAB9ASMN1; SMN2GAAMEN1
SCHEMBL20169438 0.70 GAA (0.45) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL27538197 0.68 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL2148037 0.68 ALDH1A1 (0.52) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL20593359 0.67 PSEN1 (0.39) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL26092475 0.66 MEN1 (0.55) NPC1RAB9ASMN1; SMN2HTR2CPARP1
SCHEMBL29235094 0.66 NPC1 (0.61) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL1488412 0.65 KMT2A (0.60) NPC1RAB9ASMN1; SMN2GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9975891-B2 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-22 US disclosed